肠-肝轴对小鼠肝脏缺血介导的肝细胞癌复发的影响
该研究在小鼠肝缺血再灌注(I/R)模型中探讨肠-肝轴对肝细胞癌(HCC)复发的影响,发现门脉血流阻断导致肠系膜淤血和细菌易位,通过脂多糖-Toll样受体4(LPS-Tlr4)通路加重肿瘤负荷;远程缺血预适应(RIPC)、肠道灭菌和Tlr4拮抗可减轻该效应。
要点
- 小鼠肝I/R模型中,门脉阻断引起肠系膜静脉淤血和细菌易位,加重HCC肿瘤负荷。
- RIPC通过保护肠道完整性、减少细菌易位来减轻HCC复发。
- 增强或缺陷Tlr4反应的小鼠分别显示高或低肿瘤负荷,支持LPS-Tlr4通路作用。
核心结论
- 通过RIPC、肠道灭菌和Tlr4拮抗调节肠-肝轴及LPS-Tlr4反应,是预防I/R损伤并减轻肝移植和肝切除后HCC复发的潜在治疗靶点。
研究设计与样本
- 研究使用C57Bl/6j小鼠,暴露于标准化肝I/R损伤和RIPC模型(通过阻断肝和股血管诱导),并通过门静脉注射RIL-175细胞诱导HCC。
主要发现
- 门脉三联阻断引起上游肠系膜静脉淤血和细菌易位增加,导致肿瘤负荷加重。
- RIPC通过保护肠道完整性和减少细菌易位来预防该机制,从而减轻HCC复发。
- 增强Tlr4反应的小鼠显示高肿瘤负荷,缺陷Tlr4反应的小鼠显示低肿瘤负荷,支持LPS-Tlr4通路参与。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: There is growing evidence that liver graft ischemia-reperfusion (I/R) is a risk factor for hepatocellular carcinoma (HCC) recurrence, but the mechanisms involved are unclear. Herein, we tested the hypothesis that mesenteric congestion resulting from portal blood flow interruption induces endotoxin-mediated Toll-like receptor 4 (Tlr4) engagement, resulting in elevated liver cancer burden. We also assessed the role of remote ischemic preconditioning (RIPC) in this context. METHODS: C57Bl/6j mice were exposed to standardized models of liver I/R injury and RIPC, induced by occluding the hepatic and femoral blood vessels. HCC was induced by injecting RIL-175 cells into the portal vein. We further evaluated the impact of the gut-liver axis (lipopolysaccharide (LPS)-Tlr4 pathway) in this context by studying mice with enhanced (lipopolysaccharide infusion) or defective (Tlr4-/- mice, gut sterilization, and Tlr4 antagonist) Tlr4 responses. RESULTS: Portal triad clamping provoked upstream mesenteric venous engorgement and increased bacterial translocation, resulting in aggravated tumor burden. RIPC prevented this mechanism by preserving intestinal integrity and reducing bacterial translocation, thereby mitigating HCC recurrence. These observations were linked to the LPS-Tlr4 pathway, as supported by the high and low tumor burden displayed by mice with enhanced or defective Tlr4 responses, respectively. CONCLUSIONS: Modulation of the gut-liver axis and the LPS-Tlr4 response by RIPC, gut sterilization, and Tlr4 antagonism represents a potential therapeutic target to prevent I/R lesions, and to alleviate HCC recurrence after liver transplantation and resection. LAY SUMMARY: Cancer recurrence can occur after liver resection or liver transplantation for hepatocellular carcinoma (HCC). This study suggests that intestinal venous congestion, which often occurs during liver surgery, favors the translocation of gut-derived bacterial products in the portal vein, thereby facilitating cancer recurrence by enhancing the signaling of Toll-like receptor 4 in the liver. Using a mouse model of HCC recurrence, we show that strategies that (i) reduce bacterial translocation (by gut decontamination, or by protecting the intestine from venous ischemia damage) or (ii) inhibit Tlr4 signaling in the liver, could reduce cancer recurrence.
引用
- Orci LA, Lacotte S, Delaune V, et al. Effects of the gut-liver axis on ischaemia-mediated hepatocellular carcinoma recurrence in the mouse liver. J Hepatol. 2018. PMID: 29331341. doi:10.1016/j.jhep.2017.12.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。